Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
Is measuring total IgG levels during acute myasthenia gravis exacerbations helpful for monitoring treatment or guiding the number of plasma exchange procedures?
Related Questions
How do you utilize corticosteroids in the management of CIDP?
Do you see secondary EMG/NCS abnormalities in patients with chronic upper motor neuron dysfunction such as cerebral palsy, myelopathy, or remote stroke?
Should IVIg dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
When do you consider spinal cord stimulator for patients with neuropathic pain?
How do you counsel patients with ALS on the benefits of enteral nutrition?
What typical lab tests do you send off for evaluation of neuropathy?
What testing do you order for patients with suspected dysautonomia?
How would one approach treating a patient with primary immunodeficiency on IVIG treatment who develops myasthenia gravis?
Do you send only serum paraneoplastic panels or also include CSF evaluation in patients with concern for paraneoplastic neuropathy?
How do you dose gabapentin in patients with renal failure?
